연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
495. Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.
Kang, S. Ju, W. Kim, J. W. Park, N. H. Song, Y. S. Kim, S. C. Park, S. Y. Kang, S. B. Lee, H. P.
Exp Mol Med 2006; 38(3):320-324.
Link
494. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim, S. H. Juhnn, Y. S. Kang, S. Park, S. W. Sung, M. W. Bang, Y. J. Song, Y. S.
Cellular and Molcular Life Science 2006; 63(7-8):930-938.
Link
493. Steroid receptor expressions in endometrial cancer: Clinical significance and epidemiological implication.
Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB, Lee HP, Song YS.
Cancer Letters 2006; 239(2):198-204.
Link
492. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix.
Kang SB, Kim MH, Park IA, Kim JW, Park NH, Kang D, Yoo KY, Kang SB, Lee HP, Song YS.
cancer letters 2006; 237:305-311.
Link
491. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim, S. H. Juhnn, Y. S. Kang, S. Park, S. W. Sung, M. W. Bang, Y. J. Song, Y. S.
Cellular and Molcular Life Science 2006; 63(7-8):930-938.
Link
490. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Lee KH, Lee SH, Kim DW, Kang WJ, Chung JK, Im SA, Kim TY, Kim YW, Bang YJ, Heo DS.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4232-6.
Link
489. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Lee KW, Yun T, Kim DW, Im SA, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK.
Leuk Lymphoma. 2006 Jul;47(7):1274-82.
Link
488. Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.
Lee KH, Han SW, Hwang PG, Oh DY, Kim DW, Chung DH, Im SA, Kim TY, Heo DS, Bang YJ.
Jpn J Clin Oncol. 2006 Jun;36(6):344-50.
Link
487. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ.
Clin Cancer Res. 2006 Apr 15;12(8):2538-44.
Link
486. Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.
Park SR, Baek JY, Kim DW, Im SA, Kim TY, Bang YJ, Kim NK, Jeon YK, Kim CW, Heo DS.
J Korean Med Sci. 2006 Aug;21(4):633-8.
Link